Prana Thoracic Secures $9 Million to Revolutionize Lung Cancer Treatment
Prana Thoracic, a medical device company pioneering minimally invasive lung tissue excision, today announced the closing of a $3 million extension to its Series A financing round. The additional funding brings the total capital raised to $9 million. The oversubscribed round reflects strong investor confidence in the company’s innovative approach to addressing early-stage lung cancer. …